Ray Dalio Schrodinger, Inc. Transaction History

Bridgewater Associates, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$18.65 - $28.5 $261,957 - $400,311	-14,046 Reduced 13.89%	87,113 $1.68 Million
Q1 2024 May 14, 2024	SELL	$24.74 - $35.13 $312,738 - $444,078	-12,641 Reduced 11.11%	101,159 $2.73 Million
Q4 2023 Feb 14, 2024	SELL	$21.62 - $37.21 $217,259 - $373,923	-10,049 Reduced 8.11%	113,800 $4.07 Million
Q3 2023 Nov 13, 2023	BUY	$27.34 - $55.37 $273,919 - $554,752	10,019 Added 8.8%	123,849 $3.5 Million
Q2 2023 Aug 11, 2023	BUY	$26.1 - $49.92 $8,978 - $17,172	344 Added 0.3%	113,830 $5.68 Million
Q1 2023 May 12, 2023	SELL	$18.09 - $27.61 $37,862 - $57,787	-2,093 Reduced 1.81%	113,486 $2.99 Million
Q4 2022 Feb 13, 2023	SELL	$16.24 - $26.38 $600,620 - $975,637	-36,984 Reduced 24.24%	115,579 $2.16 Million
Q3 2022 Nov 10, 2022	SELL	$23.95 - $34.71 $98,338 - $142,519	-4,106 Reduced 2.62%	152,563 $3.81 Million
Q2 2022 Aug 11, 2022	BUY	$21.39 - $35.9 $168,916 - $283,502	7,897 Added 5.31%	156,669 $4.14 Million
Q1 2022 May 13, 2022	BUY	$24.84 - $36.12 $895,780 - $1.3 Million	36,062 Added 32.0%	148,772 $5.08 Million
Q4 2021 Feb 14, 2022	SELL	$33.38 - $59.25 $309,499 - $549,366	-9,272 Reduced 7.6%	112,710 $3.93 Million
Q3 2021 Nov 12, 2021	SELL	$53.75 - $76.55 $171,301 - $243,964	-3,187 Reduced 2.55%	121,982 $6.67 Million
Q2 2021 Aug 13, 2021	BUY	$59.02 - $78.8 $7.39 Million - $9.86 Million	125,169 New	125,169 $9.46 Million

235

60.7M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.23B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.